PSMA tumor binding specificity was demonstrated by a reduction of the tumor uptake of about 75% in case of 68Ga-HBED-CC-PSMA and 111In-CC34 and more than 90% for 68Ga-CC34, 64Cu-CC34 and 111In-PSMA-617. This evidence concerns the gene FOLH1 and neoplasm.